CGTX
Cognition Therapeutics Inc
NASDAQ: CGTX · HEALTHCARE · BIOTECHNOLOGY
$1.26
+6.78% today
Updated 2026-04-30
Market cap
$114.37M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$0 – $4
Volume
1.2M
Cognition Therapeutics Inc (CGTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-88.60%
ROA
-76.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-6.95M | — | — | — |
| 2020 | $0.00 | $-10.07M | — | — | — |
| 2021 | $0.00 | $-11.72M | — | — | — |
| 2022 | $0.00 | $757000.00 | — | — | — |
| 2023 | $0.00 | $-25.79M | — | — | — |
| 2024 | $0.00 | $-33.97M | — | — | — |
| 2025 | $0.00 | $-23.49M | — | — | — |